Real world use of mepolizumab in Severe Asthma according to smoking status
J. García Rivero (Santander, Spain), E. Martínez-Moragón (Valencia, Spain), C. Pinedo (Madrid, Spain), N. Marina (Baracaldo, Spain), D. Bañas Conejero (Madrid, Spain), M. Sánchez-Herrero (Madrid, Spain)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2135
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. García Rivero (Santander, Spain), E. Martínez-Moragón (Valencia, Spain), C. Pinedo (Madrid, Spain), N. Marina (Baracaldo, Spain), D. Bañas Conejero (Madrid, Spain), M. Sánchez-Herrero (Madrid, Spain). Real world use of mepolizumab in Severe Asthma according to smoking status. 2135
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|